RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+25.65%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$918M
AUM Growth
+$918M
(+13%)
Cap. Flow
-$49.1M
Cap. Flow
% of AUM
-5.35%
Top 10 Holdings %
Top 10 Hldgs %
48.26%
Holding
69
New
15
Increased
16
Reduced
21
Closed
14
Top Buys
| 1 |
Gilead Sciences
GILD
|
$34.7M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$27.5M |
| 3 |
AstraZeneca
AZN
|
$18.2M |
| 4 |
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
|
$17.3M |
| 5 |
ARRY
Array Biopharma Inc
ARRY
|
$16.6M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$39.5M |
| 2 |
HCA Healthcare
HCA
|
$23.2M |
| 3 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$20.9M |
| 4 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
$18.8M |
| 5 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$18.1M |
Sector Composition
| 1 | Healthcare | 79.69% |
| 2 | Technology | 2.51% |
| 3 | Communication Services | 1.69% |
| 4 | Financials | 0.72% |
| 5 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MODN
26
DELISTED
MODEL N, INC.
MODN
| $15.5M | 1.69% | 1,461,678 +4,400 | +0.3% | +$46.7K |
|
27
Universal Health Services
UHS
$11.6B
| $15.1M | 1.64% | 135,270 +11,478 | +9% | +$1.28M |
|
|
CIVI
28
DELISTED
Civitas Solutions, Inc.
CIVI
| $15M | 1.63% | 879,485 +260,249 | +42% | +$4.43M |
|
29
Biogen
BIIB
$19.4B
| $14.6M | 1.59% | +43,113 | New | +$14.6M |
|
|
CSLT
30
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $14.6M | 1.59% | 1,247,268 -436,549 | -26% | -$5.11M |
|
|
OXFD
31
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $14.6M | 1.59% | 1,070,995 +4,580 | +0.4% | +$62.4K |
|
32
Globus Medical
GMED
$8.27B
| $14.5M | 1.58% | 611,731 -354,569 | -37% | -$8.43M |
|
33
Accuray
ARAY
$157M
| $11.6M | 1.26% | 1,535,475 -117,653 | -7% | -$888K |
|
|
AKAO
34
DELISTED
Achaogen, Inc.
AKAO
| $9.58M | 1.04% | 733,953 -36,469 | -5% | -$476K |
|
|
BLUE
35
DELISTED
bluebird bio
BLUE
| $9.38M | 1.02% | +102,227 | New | +$9.38M |
|
|
NVRO
36
DELISTED
NEVRO CORP.
NVRO
| $9.06M | 0.99% | +234,254 | New | +$9.06M |
|
|
CNXR
37
DELISTED
Connecture, Inc.
CNXR
| $8.5M | 0.93% | +943,000 | New | +$8.5M |
|
38
Atara Biotherapeutics
ATRA
$84.6M
| $7.07M | 0.77% | +264,266 | New | +$7.07M |
|
39
eHealth
EHTH
$118M
| $6.6M | 0.72% | 264,942 +87,154 | +49% | +$2.17M |
|
|
FLXN
40
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $6.36M | 0.69% | 315,144 -150,789 | -32% | -$3.04M |
|
41
Eledon Pharmaceuticals
ELDN
$155M
| $3.17M | 0.35% | 215,139 -199,191 | -48% | -$2.94M |
|
42
Carisma Therapeutics
CARM
$8.98M
| $2.85M | 0.31% | +240,000 | New | +$2.85M |
|
43
Pacific Biosciences
PACB
$393M
| $1.87M | 0.2% | +237,977 | New | +$1.87M |
|
|
LOXO
44
DELISTED
Loxo Oncology, Inc
LOXO
| $1.62M | 0.18% | 137,681 -402,619 | -75% | -$4.73M |
|
|
FWP
45
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $526K | 0.06% | +25,235 | New | +$526K |
|
46
Celldex Therapeutics
CLDX
$1.47B
| $476K | 0.05% | +26,100 | New | +$476K |
|
47
VanEck Pharmaceutical ETF
PPH
$621M
| $418K | 0.05% | 6,500 | – | – |
|
|
WCG
48
DELISTED
Wellcare Health Plans, Inc.
WCG
| $401K | 0.04% | 4,887 -220,146 | -98% | -$18.1M |
|
49
Invesco QQQ Trust
QQQ
$364B
| $355K | 0.04% | +3,434 | New | +$355K |
|
50
iShares Biotechnology ETF
IBB
$5.6B
| $303K | 0.03% | 1,000 -652 | -39% | -$198K |
|